Niche oncology focus Genactis specializes in strategic market research for pharma and biotech with emphasis on late-stage oncology, rare and life-limiting diseases, and precision medicine, suggesting sales opportunities in clinical trial insights, competitive benchmarking, and launch strategy services for oncology programs.

Mid-sized specialist With 11-50 employees and two decades of experience, Genactis offers boutique-depth capabilities combined with agility, making them an attractive partner for pharma and biotech firms seeking tailored market research without the overhead of large agencies.

Digital security posture Their technology stack includes Cloudflare Bot Management, reCAPTCHA, HSTS, and secure hosting, indicating a priority on data integrity and client trust, which can be leveraged when proposing secure data-driven insights and compliant research workflows.

Revenue signals Reported revenue in the range of $1M–$10M positions Genactis as a growing, mid-market supplier with potential for expansion in advisory services, continued specialization, or retainer-based research programs with pharma and biotech clients.

Market positioning Operating in Hemel Hempstead with a focus on oncology and high-need disease areas, Genactis can be considered for strategic partnerships, syndicated studies, and targeted competitive intelligence that align with pharma players accelerating oncology and precision medicine pipelines.